Working with companies that manufacture breastmilk substitutes: An EAACI position paper
Pediatric Allergy and Immunology · 2024
DOI: 10.1111/pai.14142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, 2024. Verfasst von Stefania Arasi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Diseases Research Area, Pediatric Allergology Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Milk, Human. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Academy for Allergy and Clinical Immunology.
Abstract (Originalsprache)
Breastmilk is the optimal source of nutrition for infants and should ideally be provided exclusively for the first 6 months of life, and alongside complementary food until 2 years of life. However, there are circumstances where a breastmilk substitute (BMS) may be required. This includes maternal and/or child conditions or personal preference. Whilst these circumstances should never be used as an opportunity to promote BMS, healthcare professionals (HCPs) need to have the knowledge of suitable alternatives and should always be guided by scientific and health motives when recommending a BMS. The Task Force ‘Milk Formula Industry Sponsorship’ from the European Academy of Allergy and Clinical Immunology (EAACI), provides with this publication recommendations for EAACI interactions with the BMS manufacturers and how this will be supervised.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Allergy Diseases Research Area, Pediatric Allergology Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
- Paediatric Allergy Unit, Department of Pediatrics, Gynecology and Obstetrics, University Hospital of Geneva, Geneva, Switzerland.
- Living with Allergy Association, Istanbul, Turkey.
- Unit of Allergic Diseases, Malaga Regional University Hospital, Malaga, Spain.
- Faculty of Medicine, Malaga University, Malaga, Spain.
- Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
ORCID-Profile: Stefania Arasi, Jean-Christoph Caubet, Markus Ollert
Förderung
- European Academy for Allergy and Clinical Immunology
Zitieren
APA
Arasi, S., Caubet, J. C., Ceylan, O., Eguíluz-Gracia, I., Del Giacco, S., Gelincik, A., Jutel, M., Meyer, R., Ollert, M., Torres, M. J., & Written the EAACI Formula Milk Industry Sponsorship Task Force (2024). Working with companies that manufacture breastmilk substitutes: An EAACI position paper. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14142
Vancouver
Arasi S, Caubet JC, Ceylan O, Eguíluz-Gracia I, Del Giacco S, Gelincik A, et al. Working with companies that manufacture breastmilk substitutes: An EAACI position paper. Pediatric Allergy and Immunology. 2024. doi:10.1111/pai.14142
BibTeX
@article{Arasi2024,
author = {Arasi, Stefania and Caubet, Jean-Christoph and Ceylan, Ozlem and Eguíluz-Gracia, Ibon and Del Giacco, Stefano and Gelincik, Aslı and Jutel, Marek and Meyer, Rosan and Ollert, Markus and Torres, Maria J and Written the EAACI Formula Milk Industry Sponsorship Task Force, Written the EAACI Formula Milk Industry Sponsorship Task Force},
title = {Working with companies that manufacture breastmilk substitutes: An EAACI position paper},
journal = {Pediatric Allergy and Immunology},
year = {2024},
doi = {10.1111/pai.14142}
}
EUVIMED